KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $10.92 $19.34 Friday, 26th Apr 2024 SAGE stock ended at $13.69. This is 0.81% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.96% from a day low at $13.38 to a day high of $13.91.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Apr 26, 2024 $13.87 $13.91 $13.38 $13.69 1 461 453
Apr 25, 2024 $13.62 $14.97 $13.56 $13.58 1 391 209
Apr 24, 2024 $13.85 $14.52 $13.45 $14.00 2 306 912
Apr 23, 2024 $12.91 $13.38 $12.74 $12.95 806 957
Apr 22, 2024 $13.42 $13.46 $12.89 $12.89 765 700
Apr 19, 2024 $12.93 $13.61 $12.93 $13.33 1 257 636
Apr 18, 2024 $12.24 $13.50 $12.20 $13.04 1 754 484
Apr 17, 2024 $12.96 $13.42 $10.92 $12.57 4 302 490
Apr 16, 2024 $15.22 $15.74 $15.06 $15.63 1 724 677
Apr 15, 2024 $15.60 $15.60 $15.06 $15.32 826 905
Apr 12, 2024 $16.27 $16.37 $15.28 $15.44 1 414 288
Apr 11, 2024 $16.66 $16.74 $16.24 $16.57 537 707
Apr 10, 2024 $16.10 $16.54 $15.90 $16.45 831 924
Apr 09, 2024 $16.68 $17.05 $16.27 $16.52 637 131
Apr 08, 2024 $16.48 $16.76 $16.28 $16.60 488 609
Apr 05, 2024 $16.47 $16.76 $16.00 $16.42 662 712
Apr 04, 2024 $17.05 $17.51 $16.48 $16.58 774 667
Apr 03, 2024 $17.20 $17.45 $16.75 $17.15 747 156
Apr 02, 2024 $17.67 $17.79 $17.24 $17.25 752 564
Apr 01, 2024 $18.71 $18.76 $17.80 $17.90 666 596
Mar 28, 2024 $19.06 $19.34 $18.51 $18.74 885 054
Mar 27, 2024 $18.80 $19.19 $18.71 $19.04 499 478
Mar 26, 2024 $19.25 $19.25 $18.42 $18.62 788 736
Mar 25, 2024 $19.16 $19.52 $18.60 $18.69 523 279
Mar 22, 2024 $20.23 $20.32 $19.18 $19.22 427 171
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT